Literature DB >> 11237664

Characterization of a biomaterial with cartilage-like properties expressing type X collagen generated in vitro using neonatal porcine articular and growth plate chondrocytes.

L E Estrada1, G R Dodge, D W Richardson, A Farole, S A Jimenez.   

Abstract

OBJECTIVE: The availability of cartilage with or without the potential to ossify and suitable for surgical restoration and resurfacing of joints is an important clinical problem in arthritis-related pathology, trauma and reconstructive surgery. Here, we designed experiments to generate a biomaterial with cartilage-like properties by culturing neonatal porcine articular and growth plate chondrocytes on a hydrogel substrate and to examine the biochemical and histological characteristics of the resulting tissue.
DESIGN: Neonatal porcine epiphyseal and growth plate chondrocytes were cultured on poly(2-hydroxyethyl methacrylate) (polyHEMA)-coated dishes to prevent their adherence to plastic. We previously described that this procedure allows the maintenance of the chondrocyte-specific phenotype for > or = 8 months. Chondrocytes were isolated by successive enzymatic digestions and cultured at high density (>2.0 x 10(7) cells/ml) in DMEM with 10% FBS, 50 microg/ml ascorbic acid, glutamine, vitamins, and antibiotics for up to 10 weeks on 60 mm plastic culture dishes coated with polyHEMA. The tissues produced during culture were studied histologically and biochemically and were examined for cellular proliferation employing(3)H-thymidine incorporation and for their collagen production employing biosynthetic labeling with(14)C-proline and Western blot with specific antibodies. The expression of relevant collagen genes was examined employing RT-PCR.
RESULTS: Within 24 h of culture, isolated chondrocytes organized into well-formed clusters and in 2 weeks formed structures with gross appearance and consistency similar to those of natural cartilage. The wet weight of the tissue formed in vitro increased six-fold during the 10-week period of study. Cell proliferation measured by the incorporation of(3)H-thymidine increased during the first 3 weeks and reached a plateau in subsequent weeks. Histological examination showed that the cultures contained rounded chondrocytes embedded in an abundant cartilaginous extracellular matrix. The cartilage formed contained large amounts of collagen and sulfated proteoglycans as examined by staining with Masson's Trichrome and Alcian blue, respectively. Deposition of calcium in the deeper layers of the tissue was demonstrated with the von Kossa stain. Western analyses with specific antibodies showed that type II collagen was present from the first week and progressively increased in the cultures, whereas type X collagen was first detected at 4 weeks and increased with length of culture. When chondrocytes isolated from the growth plate were included, small amounts of type I collagen were detected in the medium of cultured biomaterial as expected. Type III collagen was not detected by Western blot over the 10-week period. High levels of type II and type X collagen gene expression were demonstrated by RT-PCR.
CONCLUSION: These studies demonstrate the production in vitro of cartilage-like tissue with similar morphological, histochemical and biochemical characteristics to those of natural growth plate cartilage. The cartilage generated in vitro has the potential to be used in reconstructive surgery and in joint resurfacing and restoration of skeletal defects. Copyright 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237664     DOI: 10.1053/joca.2000.0373

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  8 in total

1.  Characterization of a cartilage-like engineered biomass using a self-aggregating suspension culture model: molecular composition using FT-IRIS.

Authors:  Minwook Kim; Jeffrey J Kraft; Andrew C Volk; Joan Pugarelli; Nancy Pleshko; George R Dodge
Journal:  J Orthop Res       Date:  2011-05-31       Impact factor: 3.494

2.  Infrapatellar fat pad-derived stem cells maintain their chondrogenic capacity in disease and can be used to engineer cartilaginous grafts of clinically relevant dimensions.

Authors:  Yurong Liu; Conor Timothy Buckley; Henrique V Almeida; Kevin J Mulhall; Daniel John Kelly
Journal:  Tissue Eng Part A       Date:  2014-07-08       Impact factor: 3.845

3.  A high-throughput model of post-traumatic osteoarthritis using engineered cartilage tissue analogs.

Authors:  B Mohanraj; G R Meloni; R L Mauck; G R Dodge
Journal:  Osteoarthritis Cartilage       Date:  2014-07-04       Impact factor: 6.576

4.  A comparison of self-assembly and hydrogel encapsulation as a means to engineer functional cartilaginous grafts using culture expanded chondrocytes.

Authors:  Tariq Mesallati; Conor T Buckley; Daniel J Kelly
Journal:  Tissue Eng Part C Methods       Date:  2013-07-12       Impact factor: 3.056

Review 5.  Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy.

Authors:  Claire Vinatier; Carine Bouffi; Christophe Merceron; Jan Gordeladze; Jean-Marc Brondello; Christian Jorgensen; Pierre Weiss; Jérome Guicheux; Danièle Noël
Journal:  Curr Stem Cell Res Ther       Date:  2009-12       Impact factor: 3.828

6.  Effects of Hydrostatic Loading on a Self-Aggregating, Suspension Culture-Derived Cartilage Tissue Analog.

Authors:  Jeffrey J Kraft; Changhoon Jeong; John E Novotny; Thomas Seacrist; Gilbert Chan; Marcin Domzalski; Christina M Turka; Dean W Richardson; George R Dodge
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

7.  Differential Behavior Between Isolated and Aggregated Rabbit Auricular Chondrocytes on Plastic Surfaces.

Authors:  V. Villar-Suárez; I. Calles-Venal; I. G. Bravo; J. G. Fernández-Alvarez; M. Fernández-Caso; J. M. Villar-Lacilla
Journal:  J Biomed Biotechnol       Date:  2004

8.  Transplantation of a Scaffold-Free Cartilage Tissue Analogue for the Treatment of Physeal Cartilage Injury of the Proximal Tibia in Rabbits.

Authors:  Sang Uk Lee; Jae Young Lee; Sun Young Joo; Yong Suk Lee; Changhoon Jeong
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.